Rimegepant for vestibular and cochlear symptoms associated with vertigo in a real-world retrospective study

Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG)

10.1186/s13063-019-3903-5 · doi-reference

A phase 4, 24-week, open-label study to evaluate the safety and tolerability of once-daily dosing of 75 mg rimegepant for episodic migraine prevention

10.1186/s10194-025-02225-7 · doi-reference

A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine

10.1177/03331024251355947 · doi-reference

The world report on hearing, 2021

10.2471/blt.21.285643 · doi-reference

Vestibular migraine: Diagnostic criteria1

10.3233/ves-201644 · doi-reference

Impact of Erenumab on Comorbid Depression, Anxiety, and Sleep Quality in Migraine: A Registry for Migraine (REFORM) Study

10.1111/ene.70402 · doi-reference

Effect of Galcanezumab on PHQ-9 and GAD-7 in Patients with Migraine: A Real-world Study in Japan

10.2169/internalmedicine.5856-25 · doi-reference

The 5-HT(1F) receptor as the target of ditans in migraine - from bench to bedside

10.1038/s41582-023-00842-x · doi-reference

Ibuprofen: pharmacology, efficacy and safety

10.1007/s10787-009-0016-x · doi-reference

Profile of Lasmiditan in the Acute Treatment of Migraine in Adults: Design, Development, and Place in Therapy

10.2147/dddt.s380440 · doi-reference

Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review

10.2165/00003088-200140030-00004 · doi-reference

Pharmacokinetics and Safety of Single and Multiple Daily Dosing of 75-mg Rimegepant Orally Disintegrating Tablets in Healthy Chinese Adults: A Randomized Placebo-Controlled Trial

10.1002/cpdd.1230 · doi-reference

Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti-CGRP Antibody, in Healthy Chinese Participants

10.1002/cpdd.1599 · doi-reference

CGRP Modulating Therapies: An Update

10.1007/s11910-024-01363-w · doi-reference

Menière's disease caused by CGRP - A new hypothesis explaining etiology and pathophysiology. Redirecting Menière's syndrome to Menière's disease

10.3233/ves-200716 · doi-reference

Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study

10.1177/03331024231161809 · doi-reference

A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study

10.1111/head.14835 · doi-reference

Effectiveness of rimegepant in vestibular migraine: a prospective self-controlled cohort study

10.1186/s10194-025-02243-5 · doi-reference

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update

10.1186/s10194-022-01431-x · doi-reference

Treating Menière's disease with rimegepant

10.57187/s.4147 · doi-reference

CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond

10.1152/physrev.00059.2021 · doi-reference

Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model

10.1186/s10194-022-01403-1 · doi-reference

Systemic calcitonin gene-related peptide modifies auditory and vestibular end organ electrical potentials, and increases sensory hypersensitivities

10.1152/jn.00226.2024 · doi-reference

Calcitonin gene-related peptide in the audiovestibular system

10.1111/head.15075 · doi-reference

Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine

10.1177/1744806918820452 · doi-reference

Neurokinins and their receptors in the rat trigeminal system: Differential localization and release with implications for migraine pain

10.1177/17448069211059400 · doi-reference

Ménière's disease and vestibular migraine: a narrative review of pathogenetic insights, diagnostic evolution, and clinical management advances

10.3389/fneur.2025.1653509 · doi-reference

Direct evidence of trigeminal innervation of the cochlear blood vessels

10.1016/s0306-4522(97)00503-4 · doi-reference

Trigeminal ganglion innervation of the cochlea--a retrograde transport study

10.1016/s0306-4522(96)00641-0 · doi-reference

Exploring Heterogeneity in Vestibular Migraine Using Individualized Differential Structural Covariance Network Analysis

10.1111/cns.70599 · doi-reference

Migraine and the trigeminovascular system-40 years and counting

10.1016/s1474-4422(19)30185-1 · doi-reference

Serotonin-induced plasma extravasation in the murine inner ear: possible mechanism of migraine-associated inner ear dysfunction

10.1111/j.1468-2982.2006.01208.x · doi-reference

Salvage treatment strategies for refractory sudden sensorineural hearing loss-a comprehensive review and meta-analysis with practical recommendations

10.3389/fneur.2025.1627892 · doi-reference

Efficacy of high dose systemic versus combined (systemic and intratympanic) corticosteroid therapy in idiopathic sudden sensorineural hearing loss: A prospective randomized trial and risk factor analysis

10.1016/j.amjoto.2023.104099 · doi-reference

Diagnosis and treatment of vertigo and dizziness : Interdisciplinary guidance paper for clinical practice

10.1007/s00106-025-01599-z · doi-reference

Association between dizziness and future falls and fall-related injuries in older adults: a systematic review and meta-analysis

10.1093/ageing/afae177 · doi-reference

Hearing loss and cognitive impairment among older adults: findings from the China health and retirement longitudinal study

10.1186/s12889-025-22860-8 · doi-reference

Hearing Loss, Hearing Aids, and Cognition

10.1001/jamanetworkopen.2024.36723 · doi-reference

Anxiety and Depression in Adults With Vestibular Disorders: A Systematic Review and Meta-Analysis

10.1002/lary.70055 · doi-reference

Association of Benign Paroxysmal Positional Vertigo with Depression and Anxiety-A Systematic Review and Meta-Analysis

10.1002/lary.30957 · doi-reference